Recursion Pharmaceuticals's Total Assets for the quarter that ended in Dec. 2023 was $653.70 Mil.
During the past 12 months, Recursion Pharmaceuticals's average Total Assets Growth Rate was 73.20% per year.
During the past 3 years, the average Total Assets Growth Rate was 93.00% per year.
During the past 5 years, Recursion Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 93.00%. The lowest was 68.70%. And the median was 80.85%.
Total Assets is connected with ROA %. Recursion Pharmaceuticals's annualizedROA % for the quarter that ended in Dec. 2023 was -57.92%. Total Assets is also linked to Revenue through Asset Turnover. Recursion Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 was 0.02.
Recursion Pharmaceuticals Total Assets Historical Data
The historical data trend for Recursion Pharmaceuticals's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Recursion Pharmaceuticals Total Assets Calculation
Total Assets are all the assets a company owns.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Recursion Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Recursion Pharmaceuticals (NAS:RXRX) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Recursion Pharmaceuticals's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Recursion Pharmaceuticals Total Assets Related Terms
Thank you for viewing the detailed overview of Recursion Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Recursion Pharmaceuticals (Recursion Pharmaceuticals) Business Description
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RXRX has been successfully added to your 